Literature DB >> 15906175

Non-native intermediate conformational states of human growth hormone in the presence of organic solvents.

Muppalla Sukumar1, Sacha M Storms, Michael R De Felippis.   

Abstract

PURPOSE: Manufacturing processes expose protein pharmaceuticals to organic solvents that may perturb the native folded state, increasing the potential for irreversible aggregation or surface adsorption. The aim of this study was to characterize the conformational states of human growth hormone (hGH) in aqueous ethanolic solutions.
METHODS: The higher order structure of hGH was investigated using far- and near-UV circular dichroism (CD) and fluorescence spectroscopy as orthogonal techniques, and the hydrodynamic size was monitored using dynamic light scattering.
RESULTS: CD data suggested that the secondary structure of hGH remained unchanged up to 50\% (v/v) ethanol, but the tertiary structure was perturbed at a20% ethanol. Fluorescence anisotropy, however, showed that the mobility of the buried Trp residue was restricted even at 30% ethanol, suggesting a differently packed structural core in 30% ethanol relative to the native structure. Consistent with this result, thermal unfolding of hGH in 30% ethanol was more facile compared to that in 0% and 20% ethanol. At >40% ethanol, fluorescence data were consistent with increased solvent exposure of the tryptophan.
CONCLUSIONS: The results point to progressive unfolding of hGH that increases solvent exposure of the hydrophobic core as a function of ethanol concentration and suggest that non-native intermediate states are populated in 30-60% ethanol.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15906175     DOI: 10.1007/s11095-005-2596-5

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  21 in total

Review 1.  Role of the molten globule state in protein folding.

Authors:  M Arai; K Kuwajima
Journal:  Adv Protein Chem       Date:  2000

Review 2.  Bioequivalence and the immunogenicity of biopharmaceuticals.

Authors:  Huub Schellekens
Journal:  Nat Rev Drug Discov       Date:  2002-06       Impact factor: 84.694

3.  Evidence for a self-associating equilibrium intermediate during folding of human growth hormone.

Authors:  M R DeFelippis; L A Alter; A H Pekar; H A Havel; D N Brems
Journal:  Biochemistry       Date:  1993-02-16       Impact factor: 3.162

Review 4.  The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation.

Authors:  J L Cleland; M F Powell; S J Shire
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1993       Impact factor: 4.889

5.  Site-directed mutagenesis to probe protein folding: evidence that the formation and aggregation of a bovine growth hormone folding intermediate are dissociable processes.

Authors:  S R Lehrman; J L Tuls; H A Havel; R J Haskell; S D Putnam; C S Tomich
Journal:  Biochemistry       Date:  1991-06-11       Impact factor: 3.162

Review 6.  Development and scale-up of a microsphere protein delivery system.

Authors:  M A Tracy
Journal:  Biotechnol Prog       Date:  1998 Jan-Feb

7.  Equilibrium denaturation of human growth hormone and its cysteine-modified forms.

Authors:  D N Brems; P L Brown; G W Becker
Journal:  J Biol Chem       Date:  1990-04-05       Impact factor: 5.157

8.  Kinetic analysis of the folding of human growth hormone. Influence of disulfide bonds.

Authors:  K M Youngman; D B Spencer; D N Brems; M R DeFelippis
Journal:  J Biol Chem       Date:  1995-08-25       Impact factor: 5.157

9.  Human growth hormone and extracellular domain of its receptor: crystal structure of the complex.

Authors:  A M de Vos; M Ultsch; A A Kossiakoff
Journal:  Science       Date:  1992-01-17       Impact factor: 47.728

10.  Thermodynamics of the denaturation of lysozyme in alcohol--water mixtures.

Authors:  G Velicelebi; J M Sturtevant
Journal:  Biochemistry       Date:  1979-04-03       Impact factor: 3.162

View more
  4 in total

1.  Protein structural conformation and not second virial coefficient relates to long-term irreversible aggregation of a monoclonal antibody and ovalbumin in solution.

Authors:  Harminder Bajaj; Vikas K Sharma; Advait Badkar; David Zeng; Sandeep Nema; Devendra S Kalonia
Journal:  Pharm Res       Date:  2006-05-25       Impact factor: 4.200

2.  Modulation of self-association and subsequent fibril formation in an alanine-rich helical polypeptide.

Authors:  Ayben Top; Kristi L Kiick; Christopher J Roberts
Journal:  Biomacromolecules       Date:  2008-05-02       Impact factor: 6.988

3.  Aqueous-soluble, non-reversible lipid conjugate of salmon calcitonin: synthesis, characterization and in vivo activity.

Authors:  Weiqiang Cheng; Seetharama Satyanarayanajois; Lee-Yong Lim
Journal:  Pharm Res       Date:  2006-11-16       Impact factor: 4.580

4.  An integrative toolbox to unlock the structure and dynamics of protein-surfactant complexes.

Authors:  Adrian Sanchez-Fernandez; Carl Diehl; Judith E Houston; Anna E Leung; James P Tellam; Sarah E Rogers; Sylvain Prevost; Stefan Ulvenlund; Helen Sjögren; Marie Wahlgren
Journal:  Nanoscale Adv       Date:  2020-07-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.